- Home
- COLL vs CRF Comparison
COLL vs CRF Comparison
Compare COLL & CRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLL | CRF |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | COLL | CRF |
|---|---|---|
| Price | $37.26 | $7.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $51.40 | N/A |
| AVG Volume (30 Days) | 433.5K | ★ 950.5K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $780,567,000.00 | N/A |
| Revenue This Year | $8.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $91.13 | ★ N/A |
| Revenue Growth | ★ 23.62 | N/A |
| 52 Week Low | $29.19 | $6.56 |
| 52 Week High | $50.79 | $8.25 |
Technical Indicators
Market Signals| Indicator | COLL | CRF |
|---|---|---|
| Relative Strength Index (RSI) | 61.58 | 44.56 |
| Support Level | $33.80 | $7.03 |
| Resistance Level | $38.50 | $7.35 |
| Average True Range (ATR) | 1.42 | 0.07 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 75.62 | 15.91 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology, Health Care, Financials, Communication Services, Consumer Discretionary, Industrials, Exchange-Traded Funds, Utilities, Energy, Real Estate, and others.